Atea Pharmaceuticals Earnings Estimate

AVIR Stock  USD 3.30  0.10  2.94%   
By analyzing Atea Pharmaceuticals' earnings estimates, investors can diagnose different trends across Atea Pharmaceuticals' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Atea Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Atea Pharmaceuticals is projected to generate -0.4294 in earnings per share on the 31st of December 2024. Atea Pharmaceuticals earnings estimates module stress-tests analyst consensus about projected Atea Pharmaceuticals EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Atea Pharmaceuticals, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Atea Pharmaceuticals' earnings estimates, investors can diagnose different trends across Atea Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Atea Pharmaceuticals' Pretax Profit Margin is relatively stable compared to the past year. As of 11/27/2024, Operating Profit Margin is likely to grow to 0.37, though Gross Profit is likely to grow to (66.6 M).
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Atea Stock, please use our How to Invest in Atea Pharmaceuticals guide.

Atea Pharmaceuticals Earnings per Share Projection vs Actual

About Atea Pharmaceuticals Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Atea Pharmaceuticals earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Atea Pharmaceuticals estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Atea Pharmaceuticals fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-195.8 M-186 M
Retained Earnings Total Equity64.4 M67.7 M
Earnings Yield(0.53)(0.51)
Price Earnings Ratio(1.87)(1.96)
Price Earnings To Growth Ratio(0.11)(0.10)

Pair Trading with Atea Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Atea Stock

  0.68VALN Valneva SE ADRPairCorr
  0.77FDMT 4D Molecular TherapeuticsPairCorr
  0.76JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.68LLY Eli Lilly Sell-off TrendPairCorr

Moving against Atea Stock

  0.72BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.59GILD Gilead SciencesPairCorr
  0.53NAMS NewAmsterdam PharmaPairCorr
  0.44LPCN LipocinePairCorr
  0.43MNOV MediciNovaPairCorr
The ability to find closely correlated positions to Atea Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea Pharmaceuticals to buy it.
The correlation of Atea Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Atea Stock Analysis

When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.